Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.95 HKD | +1.34% | +5.11% | -30.86% |
04:10am | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
Apr. 29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.86% | 1.18B | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.75% | 22.18B | |
-16.67% | 21.2B | |
-8.68% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.
- Keymed Biosciences Advances Solid Tumors Drug With First Patient Study